Table 2.

Use of Smoking Cessation Treatment After Hospital Discharge by Treatment Group^a

Outcome measure	Sustained care N=680	Standard care N=677	Relative risk (95% CI)
	%	%
Any use of smoking cessation treatment b (%)
1 month	72.2	45.2	1.60 (1.45–1.76)**
3 months (cumulative)	81.5	59.7	1.37 (1.27–1.47)**
6 months (cumulative)	85.3	66.2	1.29 (1.21–1.37)**
Any use of smoking cessation counseling b (%)
1 month	18.1	12.1	1.49 (1.15–1.93)*
3 months (cumulative)	30.1	21.0	1.44 (1.19–1.73)**
6 months (cumulative)	36.5	28.7	1.27 (1.09–1.49)*
Any use of smoking cessation medication b (%)
1 month	70.4	40.9	1.72 (1.55–1.91)**
3 months (cumulative)	80.3	54.8	1.47 (1.36–1.58)**
6 months (cumulative)	83.7	60.6	1.38 (1.29–1.48)**
Current use of smoking cessation medication c (%)
1 month follow-up	56.3	30.7	1.83 (1.61–2.09)**
3 month follow-up	42.4	25.8	1.64 (1.40–1.91)**
6 month follow-up	26.8	18.8	1.43 (1.17–1.74)**
Any use of nicotine replacement b,d (%)
1 month	68.4	39.4	1.73 (1.56–1.93)**
3 months (cumulative)	77.9	52.3	1.49 (1.37–1.62)**
6 months (cumulative)	81.6	57.5	1.42 (1.32–1.53)**
Any use of specific counseling resources e (%)
Quit Coach through study quitline vendor	20.3
Other telephone counseling (e.g., state quitline)	1.6	4.3	0.38 (0.19–0.75)*
Healthcare provider	12.1	12.6	0.96 (0.72–1.28)
Web-based counseling	6.5	8.6	0.76 (0.52–1.10)
In-person counseling	3.2	4.0	0.81 (0.47–1.41)

Note: Boldface indicates statistical significance

^*p<0.005;

^**p<0.001.

^aParticipants lost to follow-up or with missing data are counted as having received no treatment.

^bUse is defined here as starting any treatment since hospital discharge. It does not assess duration of use or use at the time when the follow-up survey was completed. Smoking cessation treatment includes counseling or any FDA-approved pharmacotherapy. Smoking cessation medication includes nicotine replacement products, bupropion, or varenicline. Smoking cessation counseling could be provided by the Alere quit coach (intervention group only) or by a doctor or other healthcare provider, hospital or community counselor, or state telephone quitline.

^cThere were no between-group differences for use of bupropion or varenicline, which were each used by <6% of study participants.

^dCurrent use is defined as use at the time of the follow-up survey. It differs from cumulative use that is reported above.

^ePercent of participants who reported ever using specific smoking cessation counseling resources at 1, 3, or 6 month assessments. Participants could endorse more than one counseling resource. The Quit Coach was only available to the Sustained Care group.